2-Aryladenine derivatives as a potent scaffold for A1, A3 and dual A1/A3 adenosine receptor antagonists: Synthesis and structure-activity relationships

Bioorg Med Chem. 2019 Aug 15;27(16):3551-3558. doi: 10.1016/j.bmc.2019.06.034. Epub 2019 Jun 20.

Abstract

From a collection containing more than 1500 academic compounds, in silico screening identified a hit for the human A1 adenosine receptor containing a new purine scaffold. To study the structure activity relationships of this new chemical series for adenosine receptors, a library of 24 purines was synthesized and tested in radioligand binding assays at human A1, A2A, A2B and A3 adenosine receptor subtypes. Fourteen molecules showed potent antagonism at A1, A3 or dual A1/A3 adenosine receptors. This purine scaffold is an important source for novel biochemical tools and/or therapeutic drugs.

Keywords: 2-Arylpurine derivatives; Adenine derivatives; Adenosine receptor antagonists.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Molecular Structure
  • Purinergic P1 Receptor Antagonists / chemistry*
  • Structure-Activity Relationship

Substances

  • Purinergic P1 Receptor Antagonists